BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories Due to Defective Applicator

Rhea-AI Summary

BD (Becton, Dickinson and Company) is voluntarily recalling specific lots of the ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator due to a manufacturing defect that can lead to broken glass and solution release. The recall affects products distributed in the United States and Puerto Rico. While no severe injuries have been reported, potential risks include superficial to deep lacerations and possible infection. BD has received 56 complaints, with one incident of laceration. The company is notifying affected customers and providing disposal instructions.

Positive

• BD is proactively recalling the affected product to mitigate potential risks.
• Customer support and instructions for replacement are being provided.

Negative

• Potential health risks include lacerations and possible infections.
• 56 complaints received regarding the defective product, indicating a serious quality control issue.

FRANKLIN LAKES, N.J., April 20, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep^™ Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) to the user level due to a defective applicator. The product is used as an antiseptic for the preparation of the patient's skin prior to surgery to help reduce bacteria that potentially can cause skin infection¹.

The ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator contains glass ampules that house the sterile ChloraPrep™ solution. In normal circumstances, the product is activated by squeezing the wing on the applicator to break the ampule, which releases the solution to the sponge head for application to the patient's skin. In certain lots, the applicator end cap was improperly secured due to a manufacturing error. This can result in broken glass and solution dropping out of the applicator once activated. In some cases, the glass ampules can drop out before activation and shatter if striking a hard surface, resulting in solution and glass fragments scattering in the procedure area and potentially causing injury to patients and health care professionals. These products were distributed in the United States and Puerto Rico.

BD Risk Assessment
Immediate health consequences could be lacerations to patient and/or user of the device.  It is possible that these could range from superficial to deep lacerations.  While BD has no current reports of severe injury, it is possible that lacerations could cause damage to structures such as nerves or tendons, however, this is considered unlikely. Long-term health consequences could include superficial or deep lacerations that could lead to infection and scarring. "Flying" glass shards could potentially cause injury to the patient or user, including eye injuries. Splashing ChloraPrep™ solution could contact the eyes of the user or patient. If tissues or organs other than the skin and subcutaneous tissues are damaged, permanent impairment could occur. While blood loss could accompany these injuries, it would be readily controllable with simple standard measures. To date, BD has received 56 complaints with only one laceration injury reported with respect to this issue.

As part of the voluntary recall to the user level, the company is notifying customers and distributors affected by the recall. BD's Customer Recall Notification provides instructions to customers and distributors for disposal and replacement of the impacted ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator (see list of affected lot numbers below).

Catalog No.	Product	Lot Number	Expiration Date
930815	BD ChloraPrep™ Hi-Lite Orange™ 26mL Applicator	0108186	04/30/2023
		0327867	11/30/2023
		0327868
		0328213
		0328947
		0328949
		0329475
		0329477
		0330457
		0330606
		0330955
		0333826
		0333852
		0333855
		0334119
		0335029
		0335787
		0335792
		0336051
		0336506
		0336972
		0337025
		0337245
		0338542
		0338653
		0338656
		0338852
		0339071
		0339457
		0339892

Customer inquiries related to this recall, as well as adverse reaction/events experienced with the product should be addressed to BD Customer Support at 1-844-8BD- LIFE (1-844-823-5433); When calling Monday- Friday between the hours of 9 a.m. to 6 p.m. ET, say "Recall" when prompted. For additional information, customers can visit www.bd-chloraprep-action.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.

The U.S. Food and Drug Administration (FDA) has been notified of this recall.

FDA MedWatch Reporting 
Adverse reactions/events experienced with the use of any of these products should also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form or submit by fax to 1-800-FDA-0178.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:
Media:	Investors:
Troy Kirkpatrick	Kristen M. Stewart, CFA
VP, Public Relations	SVP, Strategy & Investor Relations
858.617.2361	201.847.5378
troy.kirkpatrick@bd.com	kristen.stewart@bd.com

____________________
¹ https://www.bd.com/documents/labels/IP_ChloraPrep-26mL-Clear_PL.pdf

View original content to download multimedia:http://www.prnewswire.com/news-releases/bd-announces-the-voluntary-recall-of-specified-lots-of-chloraprep-hi-lite-orange-26-ml-applicator-in-the-united-states-and-us-territories-due-to-defective-applicator-301272821.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

What is the reason for the BDX recall?

BD is recalling the ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator due to a manufacturing defect that may cause broken glass and leaking solution.

How many complaints has BD received regarding the ChloraPrep™ recall?

BD has received 56 complaints related to the defective ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator.

What risks are associated with the recalled ChloraPrep™ product?

The recall poses risks of lacerations to patients or users, with potential for infection and long-term health consequences.

When was the BDX recall announced?

The recall was announced on April 20, 2021.